Authors:
Menegatti, M
Figura, N
Farinelli, S
Landi, F
Acciardi, C
Ricci, C
Holton, J
Gatta, L
Crosatti, M
Polacci, R
Miglioli, M
Vaira, D
Citation: M. Menegatti et al., Helicobacter pylori seroconversion in asymptomatic blood donors - A five-year follow-up, DIG DIS SCI, 45(8), 2000, pp. 1653-1659
Authors:
Savarino, V
Landi, F
Dulbecco, P
Ricci, C
Tessieri, L
Biagini, R
Gatta, L
Miglioli, M
Celle, G
Vaira, D
Citation: V. Savarino et al., Isotope ratio mass spectrometry (IRMS) versus laser-assisted ratio analyzer (LARA) - A comparative study using two doses of [C-13]urea and two test meals for pre- and posttreatment diagnosis of Helicobacter pylori infection, DIG DIS SCI, 45(11), 2000, pp. 2168-2174
Authors:
Gasparini, P
Arbustini, E
Restagno, G
Zelante, L
Stanziale, P
Gatta, L
Sbaiz, L
Sedita, AM
Banchieri, N
Sapone, L
Fiorucci, GC
Brinson, E
Shulse, E
Rappaport, E
Fortina, P
Citation: P. Gasparini et al., Analysis of 31 CFTR mutations by polymerase chain reaction oligonucleotideligation assay in a pilot screening of 4476 newborns for cystic fibrosis, J MED SCREE, 6(2), 1999, pp. 67-69
Citation: C. Pioli et al., Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced I chi B alpha degradation and ReIA activation, EUR J IMMUN, 29(3), 1999, pp. 856-863
Authors:
Ali', A
Menegatti, M
Gatta, L
Landi, F
Ricci, C
Acciardi, C
Miglioli, M
Vaira, D
Holton, J
Citation: A. Ali' et al., A second-line anti-Helicobacter pylori therapy in patients with previouslyfailed treatment, AM J GASTRO, 94(8), 1999, pp. 2321-2323